Institutional members access full text with Ovid®

Bimatoprost in the Treatment of Hypotrichosis

Bratton, Emily M.; Davies, Brett W.; Hink, Eric M.; Durairaj, Vikram D.

Journal of the Dermatology Nurses' Association: September/October 2013 - Volume 5 - Issue 5 - p 278–279
doi: 10.1097/JDN.0b013e3182a52462
Feature Articles

ABSTRACT: Hypotrichosis plays a role in the perception of beauty and attractiveness for many patients. Bimatoprost ophthalmic solution (0.03%; Latisse, Allergan, Inc., Irvine, CA) aids in the treatment of hypotrichosis and offers a safe and effective method of achieving fuller, darker, and longer eyelashes, creating an aesthetically pleasing outcome. Nursing staff must obtain a comprehensive basis of knowledge with regard to the pharmacology, accurate application, and side effects of the drug in order to counsel patients on appropriate use and expected outcome.

Emily M. Bratton, MD, Oculoplastic and Orbital Surgery, Department of Ophthalmology, University of Colorado Hospital, Aurora, CO.

Brett W. Davies, MD, MS, Oculoplastic and Orbital Surgery, Department of Ophthalmology, University of Colorado Hospital, Aurora, CO.

Eric M. Hink, MD, Oculoplastic and Orbital Surgery, Department of Ophthalmology, University of Colorado Hospital, Aurora, CO.

Vikram D. Durairaj, MD, FACS, Oculoplastic and Orbital Surgery, Department of Ophthalmology, University of Colorado Hospital, Aurora, CO.

The authors declare no conflicts of interest.

Correspondence concerning this article should be addressed to Vikram D. Durairaj, MD, FACS, University of Colorado Hospital, 12605 E. 16th Ave., Aurora, CO 80045. E-mail: Vikram.Durairaj@ucdenver.edu.

Copyright © 2013 by the Dermatology Nurses' Association.